YEAR: 2005
New Vistas in the Clinical Management of Depression'
Regional Medical Conference organised by Eli Lilly & the Boehringer/Ingelheim Alliance
Vienna, Austria, 27th June, 2005
27th June, 2005, Vienna, Austria
Burden & Treatment of Bipolar Depression'
Symposium supported by an unrestricted grant by GlaxoSmithKline
Brussels, 25th June, 2005
25th June, 2005, Brussels
‘Are There Any New Developments in
Depression Treatment?’
Satellite symposium supported by an unrestricted educational grant from the Lilly/Boehringer Ingelheim Alliance on the occasion of the 18th ECNP Congress
October 25th, 2005, Amsterdam
‘Innovation in Psychiatric Therapy: The Promise of the New Antipsychotics’
Satellite symposium supported by an unrestricted educational grant from Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co. Ltd. on the occasion of the 18th ECNP Congress
October 25th, 2005, Amsterdam
‘The Role of Antipsychotics in the Treatment of Bipolar Disorder’
Satellite symposium supported by an unrestricted educational grant from Pfizer Inc on the occasion of the 18th ECNP Congress
October 25th, 2005 , Amsterdam
Acting on melatonergic receptors: a milestone in the treatment of depression’
Satellite symposium on the occasion of the 18th ECNP Congress supported by an unrestricted educational grant from Servier
October 24, 2005 , Amsterdam
‘From the Clinic to the Community: Treating the Whole Schizophrenia Patient’
Satellite symposium supported by an unrestricted educational grant from Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co. Ltd. on the occasion of the 18th ECNP Congress
October 24th, 2005 , Amsterdam
‘Mood Disorders: Management and Treatment Strategies for the 21st Century’
Satellite symposium supported by an unrestricted educational grant from Wyeth Pharmaceuticals on the occasion of the 18th ECNP Congress
October 24th, 2005, Amsterdam
Bipolar disorder: a multidimensional illness requiring a multifaceted approach
Satellite symposium on the occasion of the 18th ECNP Congress supported
by an unrestricted educational grant from AstraZeneca
Monday 24 October, 2005, Amsterdam
‘Balancing Efficacy and Safety to Meet
Patients’ Needs’
Satellite symposium supported by an unrestricted educational grant from Eli Lilly
and Company on the occasion of the 18th ECNP Congress
October 23rd, 2005 , Amsterdam
‘Perspectives in Generalized Anxiety Disorder: Contrasting Today’s Reality with Tomorrow’s Vision’
Satellite symposium supported by an unrestricted educational grant from Pfizer on the occasion of the 18th ECNP Congress
October 23rd, 2005 , Amsterdam
‘Current controversies in depression and anxiety’
Satellite symposium supported by an unrestricted educational grant from H. Lundbeck A/S on the occasion of the 18th ECNP Congress
October 23rd, 2005 , Amsterdam
‘Response, Remission, Reconnection: Can we change our treatment approach in Schizophrenia?’
Satellite symposium supported by an unrestricted educational grant from Janssen-Cilag on the occasion of the 18th ECNP Congress
October 23rd, 2005 , Amsterdam
Succeeding in schizophrenia: what can be
achieved with atypical antipsychotics?
Closed meeting sponsored by AstraZeneca
23 October, 2005, Amsterdam
18th Congress of the European College of Neuropsychopharmacology
October 22-26, 2005, Amsterdam
‘Long-term Treatment Strategies for Schizophrenia: Managing the Challenges of a Lifelong Illness’
Satellite symposium supported by an unrestricted educational grant from Wyeth Pharmaceuticals and Solvay Pharmaceuticals
October 22nd, 2005 , Amsterdam
NDRIs: The Future of Treating Major Depression'
Satellite symposium on the occasion of the 18th ECNP Congress supported
by an unrestricted educational grant from GlaxoSmithKline
Saturday 22 October, 2005, Amsterdam
New Developments in Bipolar Disorder: Therapy, Tolerability and the Genetic Approach'
Satellite symposium sponsored by Bristol-Myers Squibb at the 5th International Review of Bipolar Disorders
April 21st, 2005, Lyon – France
April 21st, 2005, Lyon – France
Sustaining success in the management
of psychiatric illness
Organised by AstraZeneca
September 19-21, 2005, Monte Carlo, Monaco
45th International Neuropsychiatric
Pula Congress– EFNS
June 16th – 18th, 2005 , Pula - Croatia
Managing Psychiatric Illness: Time to Raise Expectations' Organised by AstraZeneca
15-17 February 2005, Budapest
Mind Matters '
6th International Psychiatry Forum
Organised by Sanofi-Aventis
Athens, Greece, June 10-12, 2005
June 10-12, 2005, Athens - Greece
«Schizophrenia and Bipolar Disorders: Optimising Treatment»
Meeting sponsored by Eli Lilly
October 8-9, 2005, Brussels, Belgium
7th Faculty Meeting'
Organised by the Lundbeck International Neuroscience Foundation
Athens, Greece, May 4-7, 2005
May 4-7, 2005, Athens - Greece